TRADING UPDATES: Safestay mulls asset sale; Sound Energy inks 2 deals
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Price | 150.00p on 27-06-2025 | at 18:50:06
---|---|
Change | -1.00p -0.65% |
Buy | 156.50p |
Sell | 150.00p |
Buy / Sell HEMO Shares |
Last Trade: | Sell 151.00 at 150.25p |
Day's Volume: | 102,667 |
Last Close: | 153.25p |
Open: | 150.00p |
ISIN: | GB00BQVXM815 |
Day's Range | 150.00p - 150.00p |
52wk Range: | 0.876p - 420.00p |
Market Capitalisation: | £7m |
VWAP: | 159.44397p |
Shares in Issue: | 5m |
Sector: Medicine and Biotech
Hemogenyx (HEMO) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 151 | 150.25p | Ordinary |
16:28:12 - 27-Jun-25 |
Sell* | 1,000 | 150.3282p | Ordinary |
16:19:21 - 27-Jun-25 |
Sell* | 2 | 150.00p | SI Trade |
15:48:20 - 27-Jun-25 |
Buy* | 25 | 156.50p | SI Trade |
15:48:20 - 27-Jun-25 |
Buy* | 6,423 | 154.84p | Ordinary |
15:48:15 - 27-Jun-25 |
Buy* | 323 | 152.90p | Ordinary |
15:28:08 - 27-Jun-25 |
Sell* | 507 | 149.702p | Ordinary |
15:19:22 - 27-Jun-25 |
Sell* | 671 | 149.704p | Ordinary |
15:14:31 - 27-Jun-25 |
Sell* | 98 | 149.70p | Ordinary |
14:55:28 - 27-Jun-25 |
Buy* | 800 | 152.90p | Ordinary |
14:36:09 - 27-Jun-25 |
Hemogenyx (HEMO) Regulatory News |
||
Date | Source | Headline |
---|---|---|
17th Jun 2025 7:00 am | RNS | Clearance to Proceed with Pediatric Expansion |
3rd Jun 2025 2:02 pm | RNS | Placing to Raise £451,250 and Director’s Dealing |
3rd Jun 2025 7:00 am | RNS | Second Patient Passes Initial Safety Tests |
30th May 2025 3:14 pm | RNS | Total Voting Rights |
29th May 2025 2:06 pm | RNS | Result of AGM |
14th May 2025 7:00 am | RNS-R | Pediatric Amendment to Clinical Protocol |
13th May 2025 7:00 am | RNS | AGM Correction |
8th May 2025 7:00 am | RNS | Placing to Raise £451,250 and Director’s Dealing |
2nd May 2025 4:24 pm | RNS | Notice of AGM |
2nd May 2025 7:00 am | RNS | Second Patient Treated with HG-CT-1 CAR-T Therapy |